Serum hepatitis B virus DNA in acute hepatitis B

Area of Science:

• Hepatology
• Virology
• Immunology

Background:

• Acute hepatitis B is a significant global health concern.
• Early detection of hepatitis B virus (HBV) markers is crucial for patient management.
• Understanding the dynamic interplay of HBV markers during acute infection is essential.

Purpose of the Study:

• To investigate the presence and kinetics of hepatitis B virus DNA (HBV-DNA) in patients with acute hepatitis B.
• To correlate HBV-DNA levels with other hepatitis B virus markers, including HBeAg, HBsAg, and IgM anti-HBc.
• To determine if HBV-DNA can serve as an early predictor of acute hepatitis B and to assess the risk of chronicity.

Main Methods:

• Dot blot hybridization technique used to detect HBV-DNA in serum samples.
• Analysis of serial serum samples from five patients with acute hepatitis B.
• Quantification of various hepatitis B virus markers: HBV-DNA, HBeAg, HBsAg, and IgM anti-HBc.
• Monitoring of serum alanine amino transferase (ALT) levels.

Main Results:

• Circulating HBV-DNA was detected in 43% (13/30) of patients with acute hepatitis B at their initial visit.
• HBV-DNA and HBeAg were present several days before peak serum ALT levels and the appearance of IgM anti-HBc.
• HBsAg was detectable at the time of HBV-DNA positivity.
• No correlation was observed between HBeAg titers and HBV-DNA levels in patients positive for both markers.
• None of the studied patients progressed to chronic hepatitis B infection.

Conclusions:

• HBV-DNA is a common finding in acute hepatitis B and can be detected early in the infection course.
• The presence of HBV-DNA precedes key serological markers like IgM anti-HBc and biochemical markers like elevated ALT.
• Early detection of HBV-DNA may aid in the diagnosis and management of acute hepatitis B, and this cohort showed no progression to chronicity.